Cargando…
KRAS and BRAF mutations in Iranian colorectal cancer patients: A systematic review and meta-analysis
BACKGROUND: Mutations in the EGFR signaling pathway play an important role in the development of colorectal cancer (CRC). Mutations in these genes, like KRAS and BRAF, affect the treatment strategies and associated with poor prognosis and relative resistance to anti-EGFR therapies. Our aim was to co...
Autores principales: | Yari, Abolfazl, Afzali, Asiyeh, Aalipour, Mostafa, Nakheai, Mehran, Zahedi, Mohammad Javad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Babol University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911761/ https://www.ncbi.nlm.nih.gov/pubmed/33680376 http://dx.doi.org/10.22088/cjim.11.4.355 |
Ejemplares similares
-
Sensitive High-Resolution Melting Analysis for Screening of KRAS and BRAF Mutations in Iranian Human Metastatic Colorectal Cancers
por: Niya, Mohammad Hadi Karbalaie, et al.
Publicado: (2016) -
Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma
por: Stefanius, Karoliina, et al.
Publicado: (2011) -
Mitochondrial Respiration in KRAS and BRAF Mutated Colorectal Tumors and Polyps
por: Rebane-Klemm, Egle, et al.
Publicado: (2020) -
KRAS
,
NRAS
,
BRAF, and
PIK3CA
mutation rates, clinicopathological association, and their prognostic value in Iranian colorectal cancer patients
por: Mirzapoor Abbasabadi, Zohreh, et al.
Publicado: (2023) -
Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?
por: Yokota, Tomoya
Publicado: (2012)